back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-04-04 16:27 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$11,027
+1,799 vol $6.13 each |
39,860 | |
| Filed 2023-01-04 15:27 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,602
+1,109 vol $9.56 each |
38,061 | |
| Filed 2022-12-16 16:14 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
36,952 | |
| Filed 2022-10-05 16:04 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,368
+1,165 vol $8.90 each |
16,770 | |
| Filed 2022-07-05 15:09 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,287
+823 vol $12.50 each |
15,605 | |
| Filed 2022-01-10 16:46 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$10,237
+678 vol $15.10 each |
14,098 | |
| Filed 2021-12-13 17:00 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,420 | |
| Filed 2021-12-13 17:00 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$9,980
+549 vol $18.18 each |
549 | |
| Filed 2021-12-13 16:58 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:31 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
30,254 | |
| Filed 2019-06-11 10:43 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
20,254 | |
| Filed 2018-08-23 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
DeGolyer, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
8,559 |